|
1
|
Rajaganeshan R, Prasad R, Guillou PJ,
Poston G, Scott N and Jayne DG: The role of hypoxia in recurrence
following resection of Dukes' B colorectal cancer. Int J Colorectal
Dis. 23:1049–1055. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lunt SJ, Chaudary N and Hill RP: The tumor
microenvironment and metastatic disease. Clin Exp Metastasis.
26:19–34. 2009. View Article : Google Scholar
|
|
3
|
Guillemin K and Krasnow MA: The hypoxic
response: Huffing and HIFing. Cell. 89:9–12. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Poon E, Harris AL and Ashcroft M:
Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
Expert Rev Mol Med. 11:e262009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schofield CJ and Ratcliffe PJ: Oxygen
sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 5:343–354.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Semenza GL: Regulation of mammalian
O2 homeostasis by hypoxia-inducible factor 1. Annu Rev
Cell Dev Biol. 15:551–578. 1999. View Article : Google Scholar
|
|
8
|
Maxwell PH, Wiesener MS, Chang GW,
Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and
Ratcliffe PJ: The tumour suppressor protein VHL targets
hypoxia-inducible factors for oxygen-dependent proteolysis. Nature.
399:271–275. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Semenza GL: HIF-1, O(2), and the 3 PHDs:
How animal cells signal hypoxia to the nucleus. Cell. 107:1–3.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar :
|
|
12
|
Turley EA, Veiseh M, Radisky DC and
Bissell MJ: Mechanisms of disease: Epithelial-mesenchymal
transition - does cellular plasticity fuel neoplastic progression?
Nat Clin Pract Oncol. 5:280–290. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bates RC and Mercurio AM: The
epithelial-mesenchymal transition (EMT) and colorectal cancer
progression. Cancer Biol Ther. 4:365–370. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hill RP, Marie-Egyptienne DT and Hedley
DW: Cancer stem cells, hypoxia and metastasis. Semin Radiat Oncol.
19:106–111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang MH, Wu MZ, Chiou SH, Chen PM, Chang
SY, Liu CJ, Teng SC and Wu KJ: Direct regulation of TWIST by
HIF-1alpha promotes metastasis. Nat Cell Biol. 10:295–305. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou G, Dada LA, Wu M, Kelly A, Trejo H,
Zhou Q, Varga J and Sznajder JI: Hypoxia-induced alveolar
epithelial-mesenchymal transition requires mitochondrial ROS and
hypoxia-inducible factor 1. Am J Physiol Lung Cell Mol Physiol.
297:L1120–L1130. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bork PM, Schmitz ML, Kuhnt M, Escher C and
Heinrich M: Sesquiterpene lactone containing Mexican Indian
medicinal plants and pure sesquiterpene lactones as potent
inhibitors of transcription factor NF-kappaB. FEBS Lett. 402:85–90.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Murphy JJ, Heptinstall S and Mitchell JR:
Randomised double-blind placebo-controlled trial of feverfew in
migraine prevention. Lancet. 2:189–192. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hehner SP, Heinrich M, Bork PM, Vogt M,
Ratter F, Lehmann V, Schulze-Osthoff K, Dröge W and Schmitz ML:
Sesquiterpene lactones specifically inhibit activation of NF-kappa
B by preventing the degradation of I kappa B-alpha and I kappa
B-beta. J Biol Chem. 273:1288–1297. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oka D, Nishimura K, Shiba M, Nakai Y, Arai
Y, Nakayama M, Takayama H, Inoue H, Okuyama A and Nonomura N:
Sesquiterpene lactone parthenolide suppresses tumor growth in a
xenograft model of renal cell carcinoma by inhibiting the
activation of NF-kappaB. Int J Cancer. 120:2576–2581. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kishida Y, Yoshikawa H and Myoui A:
Parthenolide, a natural inhibitor of nuclear factor-kappaB,
inhibits lung colonization of murine osteosarcoma cells. Clin
Cancer Res. 13:59–67. 2001. View Article : Google Scholar
|
|
22
|
Kim SL, Liu YC, Seo SY, Kim SH, Kim IH,
Lee SO, Lee ST, Kim DG and Kim SW: Parthenolide induces apoptosis
in colitis-associated colon cancer, inhibiting NF-κB signaling.
Oncol Lett. 9:2135–2142. 2015.PubMed/NCBI
|
|
23
|
Luo JL, Kamata H and Karin M:
IKK/NF-kappaB signaling: Balancing life and death - a new approach
to cancer therapy. J Clin Invest. 115:2625–2632. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hayden MS and Ghosh S: Signaling to
NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Royds JA, Dower SK, Qwarnstrom EE and
Lewis CE: Response of tumour cells to hypoxia: Role of p53 and
NFκB. Mol Pathol. 51:55–61. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kwon HC, Kim SH, Oh SY, Lee S, Kwon KA,
Lee JH, Choi HJ, Park KJ, Lee HS, Roh MS, et al:
Clinicopathological significance of nuclear factor-kappa B, HIF-1
alpha, and vascular endothelial growth factor expression in stage
III colorectal cancer. Cancer Sci. 101:1557–1561. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jung YJ, Isaacs JS, Lee S, Trepel J and
Neckers L: IL-1beta-mediated up-regulation of HIF-1alpha via an
NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between
inflammation and oncogenesis. FASEB J. 17:2115–2117.
2003.PubMed/NCBI
|
|
28
|
van Uden P, Kenneth NS and Rocha S:
Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem
J. 412:477–484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nam SY, Ko YS, Jung J, Yoon J, Kim YH,
Choi YJ, Park JW, Chang MS, Kim WH and Lee BL: A hypoxia-dependent
upregulation of hypoxia-inducible factor-1 by nuclear factor-κB
promotes gastric tumour growth and angiogenesis. Br J Cancer.
104:166–174. 2011. View Article : Google Scholar
|
|
30
|
Wu Y and Zhou BP:
TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and
invasion. Br J Cancer. 102:639–644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu L, Mu Y, Sa N, Wang H and Xu W: Tumor
necrosis factor α induces epithelial-mesenchymal transition and
promotes metastasis via NF-κB signaling pathway-mediated TWIST
expression in hypopharyngeal cancer. Oncol Rep. 31:321–327. 2014.
View Article : Google Scholar
|
|
32
|
Cheng ZX, Sun B, Wang SJ, Gao Y, Zhang YM,
Zhou HX, Jia G, Wang YW, Kong R, Pan SH, et al: Nuclear
factor-κB-dependent epithelial to mesenchymal transition induced by
HIF-1α activation in pancreatic cancer cells under hypoxic
conditions. PLoS One. 6:e237522011. View Article : Google Scholar
|
|
33
|
Forsythe JA, Jiang BH, Iyer NV, Agani F,
Leung SW, Koos RD and Semenza GL: Activation of vascular
endothelial growth factor gene transcription by hypoxia-inducible
factor 1. Mol Cell Biol. 16:4604–4613. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tozer GM, Kanthou C and Baguley BC:
Disrupting tumour blood vessels. Nat Rev Cancer. 5:423–435. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xia X, Lemieux ME, Li W, Carroll JS, Brown
M, Liu XS and Kung AL: Integrative analysis of HIF binding and
transactivation reveals its role in maintaining histone methylation
homeostasis. Proc Natl Acad Sci USA. 106:4260–4265. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu S, Zhou Y, Wang L, Zhang J and Wu H,
Xiong J, Zhang J, Tian Y, Wang C and Wu H: Transcriptional
upregulation of MT2-MMP in response to hypoxia is promoted by
HIF-1α in cancer cells. Mol Carcinog. 50:770–780. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ambrosio MR, Di Serio C, Danza G, Rocca
BJ, Ginori A, Prudovsky I, Marchionni N, Del Vecchio MT and
Tarantini F: Carbonic anhydrase IX is a marker of hypoxia and
correlates with higher Gleason scores and ISUP grading in prostate
cancer. Diagn Pathol. 11:452016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim SL, Trang KT, Kim SH, Kim IH, Lee SO,
Lee ST, Kim DG and Kim SW: Parthenolide suppresses tumor growth in
a xenograft model of colorectal cancer cells by inducing
mitochondrial dysfunction and apoptosis. Int J Oncol. 41:1547–1553.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bonello S, Zähringer C, BelAiba RS,
Djordjevic T, Hess J, Michiels C, Kietzmann T and Görlach A:
Reactive oxygen species activate the HIF-1alpha promoter via a
functional NFkappaB site. Arterioscler Thromb Vasc Biol.
27:755–761. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cummins EP, Berra E, Comerford KM,
Ginouves A, Fitzgerald KT, Seeballuck F, Godson C, Nielsen JE,
Moynagh P, Pouyssegur J, et al: Prolyl hydroxylase-1 negatively
regulates IkappaB kinase-beta, giving insight into hypoxia-induced
NFkappaB activity. Proc Natl Acad Sci USA. 103:18154–18159. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Koong AC, Chen EY and Giaccia AJ: Hypoxia
causes the activation of nuclear factor kappa B through the
phosphorylation of I kappa B alpha on tyrosine residues. Cancer
Res. 54:1425–1430. 1994.PubMed/NCBI
|
|
43
|
Rius J, Guma M, Schachtrup C, Akassoglou
K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG and Karin M:
NF-kappaB links innate immunity to the hypoxic response through
transcriptional regulation of HIF-1alpha. Nature. 453:807–811.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Belaiba RS, Bonello S, Zähringer C,
Schmidt S, Hess J, Kietzmann T and Görlach A: Hypoxia up-regulates
hypoxia-inducible factor-1alpha transcription by involving
phosphatidylinositol 3-kinase and nuclear factor kappaB in
pulmonary artery smooth muscle cells. Mol Biol Cell. 18:4691–4697.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huang S, DeGuzman A, Bucana CD and Fidler
IJ: Nuclear factor-kappaB activity correlates with growth,
angiogenesis, and metastasis of human melanoma cells in nude mice.
Clin Cancer Res. 6:2573–2581. 2000.PubMed/NCBI
|
|
46
|
Tsujii M, Kawano S, Tsuji S, Sawaoka H,
Hori M and DuBois RN: Cyclooxygenase regulates angiogenesis induced
by colon cancer cells. Cell. 93:705–716. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kim SL, Lee ST, Trang KT, Kim SH, Kim IH,
Lee SO, Kim DG and Kim SW: Parthenolide exerts inhibitory effects
on angiogenesis through the downregulation of VEGF/VEGFRs in
colorectal cancer. Int J Mol Med. 33:1261–1267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Semenza GL, Roth PH, Fang HM and Wang GL:
Transcriptional regulation of genes encoding glycolytic enzymes by
hypoxia-inducible factor 1. J Biol Chem. 269:23757–23763.
1994.PubMed/NCBI
|
|
49
|
Joshi S, Singh AR and Durden DL: MDM2
regulates hypoxic hypoxia-inducible factor 1α stability in an E3
ligase, proteasome, and PTEN-phosphatidylinositol
3-kinase-AKT-dependent manner. J Biol Chem. 289:22785–22797. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mottet D, Dumont V, Deccache Y, Demazy C,
Ninane N, Raes M and Michiels C: Regulation of hypoxia-inducible
factor-1alpha protein level during hypoxic conditions by the
phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta
pathway in HepG2 cells. J Biol Chem. 278:31277–31285. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Huang X, He Z, Jiang X, Hou M, Tang Z,
Zhen X, Liang Y and Ma J: Folic acid represses hypoxia-induced
inflammation in THP-1 cells through inhibition of the
PI3K/Akt/HIF-1α pathway. PLoS One. 11:e01515532016. View Article : Google Scholar
|
|
52
|
Hur E, Chang KY, Lee E, Lee SK and Park H:
Mitogen-activated protein kinase kinase inhibitor PD98059 blocks
the transactivation but not the stabilization or DNA binding
ability of hypoxia-inducible factor-1alpha. Mol Pharmacol.
59:1216–1224. 2001.PubMed/NCBI
|
|
53
|
Cannito S, Novo E, Compagnone A, Valfrè di
Bonzo L, Busletta C, Zamara E, Paternostro C, Povero D, Bandino A,
Bozzo F, et al: Redox mechanisms switch on hypoxia-dependent
epithelial-mesenchymal transition in cancer cells. Carcinogenesis.
29:2267–2278. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Jiang J, Tang YL and Liang XH: EMT: A new
vision of hypoxia promoting cancer progression. Cancer Biol Ther.
11:714–723. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chuang MJ, Sun KH, Tang SJ, Deng MW, Wu
YH, Sung JS, Cha TL and Sun GH: Tumor-derived tumor necrosis
factor-alpha promotes progression and epithelial-mesenchymal
transition in renal cell carcinoma cells. Cancer Sci. 99:905–913.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Sullivan NJ, Sasser AK, Axel AE, Vesuna F,
Raman V, Ramirez N, Oberyszyn TM and Hall BM: Interleukin-6 induces
an epithelial-mesenchymal transition phenotype in human breast
cancer cells. Oncogene. 28:2940–2947. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
John MA St, Dohadwala M, Luo J, Wang G,
Lee G, Shih H, Heinrich E, Krysan K, Walser T, Hazra S, et al:
Proinflammatory mediators upregulate snail in head and neck
squamous cell carcinoma. Clin Cancer Res. 15:6018–27. 2009.
View Article : Google Scholar
|
|
58
|
Cheng ZX, Wang DW, Liu T, Liu WX, Xia WB,
Xu J, Zhang YH, Qu YK, Guo LQ, Ding L, et al: Effects of the HIF-1α
and NF-κB loop on epithelial-mesenchymal transition and
chemoresistance induced by hypoxia in pancreatic cancer cells.
Oncol Rep. 31:1891–1898. 2014.PubMed/NCBI
|
